Showing results (3561-3570 of 9,339) with videos related to

Sort By:
Pageof 934
Cancer Medicine|July 2, 2024
Outcomes of hepatocellular carcinoma patients treated in the lenvatinib and immunotherapy era (2018-2021) compared to the sorafenib era (2008-2018)Chloe A Lim, Carla P Amaro, Philip Q Ding, et al.
Cancer Medicine|July 3, 2024
A qualitative study of stakeholders' experiences with and acceptability of a technology-supported health coaching intervention (SHARE-S) delivered in coordination with cancer survivorship careSarah N Price, Thomas K Houston, Rajani S Sadasivam, et al.
Cancer Medicine|August 21, 2024
The prevalence and prognostic value of systemic inflammation in good performance status patients with advanced, inoperable non-small cell lung cancer receiving palliative radiotherapy: Comparison of composite ratios and cumulative scoresJosh McGovern, Fraser O'Rourke, Sarah Will, et al.
Cancer Medicine|August 21, 2024
Multidisciplinary care meeting practices across diverse international settingsAlisha R Pershad, Dylan Graetz, Mai An Le, et al.
Cancer Medicine|September 5, 2024
A predictive risk-scoring model for survival prognosis of multiple myeloma based on gain/amplification of 1q21: Experience in a tertiary hospital in South-Western ChinaYanqiu Xiong, Shanshan Liang, Wenjiao Tang, et al.
Cancer Medicine|September 3, 2024
Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemiaCamille Tessier, Richard LeBlanc, Jean Roy, et al.
Cancer Medicine|September 6, 2024
Gender and melanoma subtype-based prognostic implications of MUC16 and TTN co-occurrent mutations in melanoma: A retrospective multi-study analysisNilesh Kodali, Simona Alomary, Abhijit Bhattaru, et al.
Cancer Medicine|August 28, 2024
Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical managementGiovanni Innella, Cristina Fortuno, Laura Caleca, et al.
Cancer Medicine|August 23, 2024
Impact of M-protein detection on the response evaluations of patients undergoing treatment with the IgG-κ monoclonal antibodies daratumumab or isatuximab, and discrepancies between immunofixation electrophoresis (IFE) systems and reagentsYuko Shirouchi, Kazumi Kaihara, Tsunaki Sekita, et al.
Cancer Medicine|September 2, 2024
Effect of nucleos(t)ide analogue discontinuation on the prognosis of HBeAg-negative hepatitis B virus-related hepatocellular carcinoma after hepatectomy: A propensity score matching analysisTing Sun, Yiwen Qiu, Tao Wang, et al.
Pageof 934